PINK:RAFA

Rafarma Pharmaceuticals Stock Forecast

etoro logo Buy RAFA
*Your capital is at risk
$0.0202
+0 (+0%)
At Close: Jul 06, 2026
AI Analysis AI Analysis of RAFA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RAFA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Monday for Rafarma Pharmaceuticals, Inc.
(Updated on Jul 06, 2026)

Hold candidate since Jul 02, 2026

No changes to the price of Rafarma Pharmaceuticals, Inc. stock on the last trading day (Monday, 6th Jul 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0202 to a day high of $0.0202. The price has been going up and down for this period, and there has been a -57.38% loss for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -44.42% during the next 3 months and, with a 90% probability hold a price between $0.0039 and $0.0264 at the end of this 3-month period.

RAFA Signals & Forecast

There are mixed signals in the stock today. The Rafarma Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0265 and $0.0443. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Tuesday, June 30, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Rafarma Pharmaceuticals, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 11.88%

Our recommended stop-loss: $0.0189 (-6.30%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (RAFA) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect Rafarma Pharmaceuticals, Inc. to open at $0.0202, and during the day (based on 14 day Average True Range), to move between $0.0179 and $0.0225, which gives a possible trading interval of +/-$0.0047 (+/-26.12%) up or down from last closing price. If Rafarma Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 26.12% move between the lowest and the highest trading price during the day.

Is Rafarma Pharmaceuticals, Inc. stock A Buy?

Rafarma Pharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 7, 2026 - $0.0202 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RAFA Performance

Trading levels for RAFA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0202 -
R2 0.0202 -
R1 0.0202 -
Price 0.0202
S1 0.0202 -
S2 0.0202 -
S3 0.0202 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 0.0202
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Rafarma Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Rafarma Pharmaceuticals, Inc. is RAFA and it is traded on the PINK (Pink Sheets).

Should I buy or sell Rafarma Pharmaceuticals, Inc. Stock?
Rafarma Pharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Rafarma Pharmaceuticals, Inc. Stock?
Rafarma Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rafarma Pharmaceuticals, Inc. Stock.

What's the current price of Rafarma Pharmaceuticals, Inc. Stock?
As of the end of day on the Jul 06, 2026, the price of an Rafarma Pharmaceuticals, Inc. (RAFA) share was $0.0202.

What is the 52-week high and low for Rafarma Pharmaceuticals, Inc. Stock?
The 52-week high for Rafarma Pharmaceuticals, Inc. Stock is $0.0985 and the 52-week low is $0.0036.

What is the market capitalization of Rafarma Pharmaceuticals, Inc. Stock?
As of the Jul 06, 2026, the market capitalization of Rafarma Pharmaceuticals, Inc. is 1.773M.
Click to get the best stock tips daily for free!
ABOUT RAFARMA PHARMACEUTICALS, INC.
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
12.69% Jun 29
OSIS
$218.29
1.16% Jun 26
NMRK
$15.02
3.86% Jun 24
TTEK
$28.04
11.09% Jun 23
NESR
$25.07
10.21% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE